»Understanding local particularities and strategic relation building is key for long-term success.«

»Understanding local particularities and strategic relation building is key for long-term success.«

visual_paris

Paul J. Sekhri

Paul J Sekhri
President & CEO
Lycera

Paul Sekhri joined Lycera as President and CEO in February 2015. Prior to this, he served as Senior Vice President, Integrated Care for Sanofi from April 2014 through January 2015. Previously, he served as Group Executive Vice President, Global Business Development and Chief Strategy Officer for Teva Pharmaceutical Industries, Ltd. Prior to joining, Teva he spent five years as Operating Partner and Head of the Biotechnology Operating Group at TPG Biotech, the life sciences venture capital arm of TPG Capital. From 2004-2009, Mr. Sekhri was Founder, President, and Chief Executive Officer of Cerimon Pharmaceuticals, Inc. Prior to founding Cerimon, Mr. Sekhri was President and ChiefBusiness Officer ofARIAD Pharmaceuticals, Inc.

From 1999-2002 Mr. Sekhri worked for Novartis AG, as Senior Vice President, and Head of Global Search and Evaluation, Business Development and Licensing for Novartis Pharma AG. Mr. Sekhri also developed the Disease Area Strategy for Novartis, identifying those specific therapeutic areas upon which the company would focus. His first role at Novartis was as Global Head, Early Commercial Development – a department he established to ensure the differential competitive advantage ofNovartis’ pipeline.

Mr. Sekhri completed graduate work in Neuroscience at the University of Maryland School of Medicine, where he also received his BS in Zoology.

Mr. Sekhri has been a Director on more than 24 private and public company Boards and is currently a member of the Board of Directors of Veeva Systems Inc., and Alpine Immune Sciences Inc. Mr. Sekhri is also the Chairman of the Board of Compugen Ltd., Pharming N.V ., Petra Pharma Inc., and Topas Therapeutics GmbH.

Additionally, he serves on several non-profit Boards including the TB Alliance, The English Concert in America (TECA), The Knights, the Caramoor Center for Music and the Arts, and most recently he joined the Board of the Metropolitan Opera. Mr. Sekhri also served as a Member of the Board of Trustees of Carnegie Hall from 2010- 2012, where he is now an active member of their Patrons Council.

Copyright © 2018 by Boston BioCapital™. All rights reserved.Print